Jul 28, 2026 07:26AM
Jul 6, 2026 05:41AM
Jun 10, 2026 05:19AM
May 26, 2026 03:55AM
May 14, 2026 02:30AM
Apr 29, 2026 03:24AM
Feb 3, 2026 09:30PM GSK preview – likely to guide modest FY26 growth betting on vaccines and specialty drugs
Jul 30, 2025 05:10PM
Jun 3, 2025 09:13AM
Apr 30, 2025 09:02AM
Apr 30, 2025 02:10AM
Apr 29, 2025 04:00PM
Apr 28, 2025 11:34AM
Feb 5, 2025 01:27PM GlaxoSmithKline (GSK) PT Lowered to $40 at CFRA
Feb 5, 2025 05:38AM
Oct 31, 2024 03:09AM
Oct 10, 2024 02:42AM
Aug 6, 2024 04:05PM
Aug 6, 2024 08:30AM
Jun 27, 2024 12:09PM
May 30, 2024 10:26AM Goldman Sachs initiates cover on six European pharma stocks
May 30, 2024 03:22AM
May 17, 2024 02:21AM
May 1, 2024 06:40AM
May 1, 2024 04:21AM
May 1, 2024 02:07AM
Mar 26, 2024 09:53AM
Feb 12, 2024 06:01AM The European version of Magnificent 7 is trading at a 30% discount - Goldman
Jan 31, 2024 04:26PM
Jan 31, 2024 02:13AM
Nov 1, 2023 04:48AM
Oct 30, 2023 06:35AM
Aug 7, 2023 04:01PM
Jul 26, 2023 05:13AM
May 12, 2023 04:01PM BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
May 11, 2023 07:00AM
May 2, 2023 04:01PM
Apr 26, 2023 07:03AM
Dec 7, 2022 04:12AM
Nov 11, 2022 09:26AM
Nov 11, 2022 08:54AM
Nov 11, 2022 07:55AM UPDATE: UBS Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Sell
Nov 10, 2022 05:23AM
Nov 2, 2022 08:42AM
Nov 2, 2022 08:16AM
Nov 2, 2022 05:50AM
Oct 13, 2022 07:26AM
Aug 11, 2022 08:49AM
Aug 11, 2022 07:00AM Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Aug 8, 2022 04:02PM

1,216,204 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All